Skip to main content
hello world

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Stocks in play: HLS Therapeutics Inc.

Baystreet - Wed Aug 28, 8:54AM CDT

Announces that CEO Craig Millian, Chief Executive Officer, will present at H.C. Wainwright's 26th Annual Global Investment Conference, which takes place September 9-11, at the Lotte New York Palace Hotel in New York City. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $3.16.